February 09, 2021
We continue our coverage of Longevity Therapeutics 2021 and bring you part 2 of day 1. Read the first article of the series here. Dr. Steven Braithwhite - Chief Scientific Officer, Alkahest Steven Braithwhite from Alkahest gave an update on the company’s ongoing clinical trials. Alkahest has been sifting plasma proteome in search for proteins...
